Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors

Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors

Interleukin-17 inhibitors are effective in psoriasis; however, they are associated with an increased risk of infections, particularly oral candidiasis, and new-onset/flares of inflammatory bowel disease. This study aimed to identify predictive markers for these adverse events and to describe the fun...

Full description

Saved in:
Bibliographic Details
Main Authors: Christopher Willy Schwarz, Charlotte Näslund-Koch, Claus Zachariae, Jakob Benedict Seidelin, Susanne Dam Nielsen, Sisse Rye Ostrowski, Karen Marie Thyssen Astvad, Inger Brock, Lars Iversen, Mads Kirchheiner Rasmussen, Nikolai Loft, Lone Skov
Format: Article
Language:English
Published: Medical Journals Sweden 2025-08-01
Series:Acta Dermato-Venereologica
Subjects:
Adalimumab
Candidiasis
Immunity
Inflammatory Bowel Diseases
Interleukin-17
S100 Proteins
Online Access:https://medicaljournalssweden.se/actadv/article/view/43685
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://medicaljournalssweden.se/actadv/article/view/43685

Similar Items